RecruitingPhase 3
An Investigation of FID 123472 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness in Adults
Alcon Research · NCT07578363
View Study & Apply (opens in a new tab)
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Phase 3
- Target enrollment
- 178
- US sites recruiting
- 3
- Study start
- September 27, 2026
- Record last updated
- October 16, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to evaluate the efficacy and safety of an investigational ophthalmic solution in adults with ocular redness caused by minor eye irritations.
Being studied: Apraclonidine Ophthalmic Solution, 0.125% Unit Dose Preservative Free; Vehicle
Conditions: Ocular Hyperemia
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Key Inclusion Criteria
- Capable of giving signed informed consent and comply with the requirements listed in the Informed Consent Form.
- Willing and able to follow all instructions and attend all study visits.
- History of redness relief eyedrop use within the last 6 months, or an interest in using over-the-counter redness relief drops, or would benefit from the use of redness relief drops in the investigator's opinion.
- Baseline ocular redness score of 0.5 unit or higher in at least one eye at Visit 1 and greater than 1 unit on a 5-point scale in both eyes prior to randomization at Visit 2.
- Other protocol-defined inclusion criteria may apply.
Key Exclusion Criteria
- Known contraindications or sensitivity to the use of any of the study treatment(s) or their components, or any other medication required by the protocol.
- Ocular surgical interventions within 6 months prior to Visit 1 or during the study.
- Any ocular condition that, in the opinion of the investigator, may compromise the subject's safety or study parameters.
- Use of prohibited medications, devices, or treatments as specified in the protocol.
- Out of range vital signs (blood pressure and/or pulse rate) as defined in the study protocol.
- Abnormal intraocular pressure.
- Other protocol-defined exclusion criteria may apply.
Recruiting US locations
Oculus Research, Inc.
Garner, NC 27529
Total Eye Care PA
Memphis, TN 38119
Piedmont Eye Center
Lynchburg, VA 24501
Study contacts (from the official record)
- Alcon Call Center · 1-888-451-3937 · alcon.medinfo@alcon.com